Letrozole Cotreatment Reduces Unexpectedly Poor Responses in Ovarian Stimulation With Follitropin Delta: A Strategy to Prevent High Anti-Müllerian Hormone (AMH) but Poor Response
Cotreatment with letrozole may reduce unanticipated suboptimal responses in patients expected to have good responses. Additionally, it may shorten the duration of ovarian stimulation and decrease the total dosage of follitropin delta required.
Authors
- Mariko Shindo (ORCID: https://orcid.org/0009-0005-6407-5268)
- Kana Inukai
- Naoko Murakami
- Koichiro Lee
- Hiromasa Kuroda (ORCID: https://orcid.org/0000-0003-4300-5517)
- Motomichi Koyama (ORCID: https://orcid.org/0000-0002-5006-9976)
- Kanako Ishii (ORCID: https://orcid.org/0000-0002-8404-7126)
- Masayo Yamada
- A. Haruki
- Akiko Shibaike
Institutions
- Ladies College (LK)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-04
- DOI
- https://doi.org/10.7759/cureus.78513
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00